Find uplifting stories about heroes, innovations, and solutions
1119 results for "hepatitis e"
A medication already being tested for hepatitis C shows promising results against hepatitis E, a deadly virus that kills 70,000 people yearly and has no approved treatment. Scientists discovered bemnifosbuvir stops the virus from replicating without harming healthy cells.
Hobart is ditching shared e-scooters and doubling down on e-bikes after the program helped residents take over 13,000 monthly trips while cutting emissions. The city joins a global trend proving greener transport can work when it fits local needs.
New World Health Organization data shows hepatitis C deaths have fallen 12% globally since 2015, with childhood hepatitis B infections down to just 0.6%. Countries like Egypt, Georgia, and Rwanda are proving that eliminating this deadly disease is possible with the right commitment and tools.
A groundbreaking hepatitis B treatment has achieved what was once thought impossible: completely clearing the virus from patients' bodies. One in five participants in recent trials are now virus-free, offering hope to 296 million people worldwide living with chronic hepatitis B.
After years without any approved therapies, adults living with chronic hepatitis delta virus now have hope with the FDA's approval of Hepcludex, the first treatment for one of the most severe forms of viral hepatitis. This breakthrough fills a critical gap for nearly 200,000 Americans who face rapid progression to serious liver complications.
Electric scooters and e-bikes are flying off the shelves in New Zealand as rising petrol prices push more people toward affordable, eco-friendly transportation. TradeMe searches for e-scooters jumped 68% compared to last year, signaling a major shift in how Kiwis get around.
Oregon's new bill drops the legal e-bike riding age from 16 to 14, allowing schools to finally teach safety to the teens already riding. While other states ban e-bikes, Oregon is choosing education over restriction.
Massachusetts is introducing a groundbreaking four-tier speed system that could finally bring clarity to the confusing world of e-bikes, scooters, and electric micromobility devices. Instead of banning faster e-bikes outright, the state is carving out sensible rules that keep riders safe while preserving access to bike infrastructure.
California lawmakers are closing a loophole that lets e-bike makers sell much more powerful bikes than legally allowed, aiming to reduce serious injuries among young riders. The new bill would cap e-bikes at 750 watts of peak power, not just continuous output.
A groundbreaking hepatitis D treatment just won approval in China, offering hope to 12 million people worldwide living with one of the most severe forms of viral hepatitis. The drug represents a rare full-journey innovation, from basic science discovery to market-ready medicine, all developed domestically.
A longtime e-bike enthusiast who once treated his electric bicycle like a motorcycle has found unexpected joy in pedaling again. His gradual shift from full-throttle commuting to low-assist riding shows how e-bikes can bring people closer to traditional cycling, not further away.
A new treatment for one of the deadliest forms of viral hepatitis just got approved in China, offering hope to 12 million people worldwide who had almost no options. The drug, developed entirely in China from discovery to delivery, blocks both hepatitis B and D viruses from entering liver cells.
Aussie commuters are ditching their cars for e-bikes as fuel prices surge, with one Perth shop selling 30 e-bikes in 10 days instead of their usual four per week. The shift could save riders thousands while building healthier, greener communities.
After 18 years of free health screenings and advocacy, Ghanaian musician Okyeame Kwame earns official recognition as National Hepatitis Ambassador. His decades of service across health, trade, and culture prove celebrities can build lasting national impact.
England is set to become one of the first countries in the world to eliminate hepatitis C, a deadly liver virus that's been silently affecting tens of thousands. Simple treatments and innovative testing programs are driving this remarkable public health victory.
A simple fingerstick test for hepatitis B is just as accurate as traditional lab testing, and delivers results in 60 minutes instead of days. This breakthrough could save lives by bringing testing to remote communities where 254 million people worldwide need better access to care.
A team of researchers across five countries just received $24 million to find a cure for hepatitis B, a virus that affects 300 million people worldwide. The five-year effort could finally bring hope to millions living with a disease that currently has no cure.
Switching just a fraction of your car trips to an e-bike could save nearly $1,000 annually, and the real surprise isn't fuel costs. The hidden savings in maintenance, parking, and potentially eliminating a second car are transforming family budgets across America.
After 40 years of prevention-only treatments, European researchers are developing the first therapies that could free 254 million people from lifelong hepatitis B. Two major clinical trials show new immune-based approaches may finally achieve what vaccines alone couldn't: a functional cure.
A lightweight folding e-bike now charges via USB-C, turning any laptop charger into a power source. At under 42 pounds and €999, it's making portable urban biking more accessible than ever.
Showing 20 of 1119